课题基金 / 基金详情

INORGANIC BORON AND COPPER ANTIBODY LABELS FOR BIOMEDICAL APPLICATIONS

INORGANIC BORON AND COPPER ANTIBODY LABELS FOR BIOMEDICAL APPLICATIONS
用于生物医学应用的无机硼和铜抗体标签
批准号:
6204068
负责人:
JOHN R WRIGHT
金额:
$7.69万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2000-07-31

项目摘要

项目成果

JOHN R WRIGHT的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的最终目标是演示合成的 新型抗体连接形式的无机同位素的可行性,以及 拟议的工作遵循这样的假设,即抗体与毒素和 诊断探针有可能以肿瘤组织为靶点 高特异性。人工合成的尝试将集中在含硼化合物上 因为稳定同位素10B被认为是一种药理学 硼-中子俘获疗法(BNCT)中的试剂和一种特殊类别的试剂 因为短寿命的同位素64Cu(一半) LIFE 12.8h)是正电子发射体,对正电子发射很有意义 体层摄影术(PET),一种诊断方法。拟议的研究是 因此具有生物医学上的相关性,因为它将试图准备一种新的 药理候选物质按合理设计。如果 这项工作是成功的,如果更大的生物医学界选择 将设想的物质开发成实际技术,然后工作 可能会对肿瘤疾病产生影响。关于硼的调查 将专注于聚合物的胶体分散,该聚合物包含 苯基硼酸结构单元和已建立的钯 将尝试使用与芳基卤化物的催化偶联反应 将这种胶体的表面修饰成适合于交联的形式 用免疫球蛋白。同样,要么是既定的酰胺化 与阳离子实体(多胺)的反应或强相互作用将 是尝试将铜簇合物连接到 免疫球蛋白。生物特异性将通过一种容易的 可用的抗原及其相应的抗体,如BSA和抗BSA。
英文摘要
The ultimate objective of this project is to demonstrate the synthetic feasibility of novel antibody linked forms of inorganic isotopes, and the proposed work follows the hypothesis that antibody linked toxins and diagnostic probes have the potential for targeting neoplastic tissue with high specificity. Synthetic attempts will focus on boron compounds because the stable isotope 10B is being considered as a pharmacologic agent in boron-neutron capture therapies (BNCT), and on a special class of copper cluster compounds because the short-lived isotope 64Cu (half life 12.8h) is a positron emitter and of interest to positron emission tomography (PET), a diagnostic methodology. The proposed research is thus biomedically relevant because it will attempt to prepare novel pharmacological candidate substances according to a rational design. If the work is successful and if the larger biomedical community chooses to develop the envisioned substances into actual technologies, then the work could have an impact upon neoplastic diseases. The boron investigation will focus on colloidal dispersions of a polymer which contains the phenylboronic acid structural unit, and an established palladium catalyzed coupling reaction with aryl halides will be used in an attempt to modify the surface of this colloid to a form suitable for crosslinking with immunoglobulins. Similarly, either an established amidation reaction or a strong interaction with cationic entities (polyamines) will be the basis of an attempt to link the copper cluster compounds to immunoglobulins. Biological specificity will be tested with a readily available antigen and its corresponding antibody, e.g., BSA and anti-BSA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RESEARCH INITIATIVE FOR SCIENTIFIC ENHANCEMENT AT SEOSU
RESEARCH INITIATIVE FOR SCIENTIFIC ENHANCEMENT AT SEOSU
RESEARCH INITIATIVE FOR SCIENTIFIC ENHANCEMENT AT SEOSU
RESEARCH INITIATIVE FOR SCIENTIFIC ENHANCEMENT AT SEOSU
海外基金